DTC and DTP pharma marketing is entering a new era, but growth now comes with a visibility problem.
As privacy regulations expand and enforcement intensifies, the same funnels driving patient acquisition, telehealth consults, and prescription fills are breaking down. Marketers are losing sight of performance at the exact moments that matter most, while compliance teams struggle to track how data flows across an increasingly complex ecosystem.
The result is fragmented data, slower campaigns, and missed opportunities to connect marketing efforts to real patient outcomes.
This benchmark report, based on insights from 200 marketing and privacy leaders, reveals how privacy constraints are reshaping DTC and DTP strategy—and why fragmentation, not regulation, is the real barrier to growth.
What You'll Learn
- Why 83% of pharma marketers lose visibility between website visits and prescription fills and how that impacts ROI
- Where compliance-driven blind spots are breaking attribution across telehealth, pharmacy, and patient engagement journeys
- How reactive tactics like avoiding ad platforms or anonymizing data are quietly limiting performance and innovation
- What high-performing teams are doing differently to align privacy, compliance, and measurement for scalable growth
